Effect of telemedicine-delivered lifestyle interventions in older adults during the COVID-19 pandemic: a nationwide two-arm randomized trial (PROACTIVE-19)
Abstract Older adults are at increased risk of severe COVID-19 outcomes, yet randomized evidence on structured lifestyle interventions in this context remains limited. We aimed to evaluate the effects of a personalized lifestyle intervention on health-related behaviors and adverse outcomes among adults aged ≥ 60 years during the COVID-19 pandemic. PROACTIVE-19 was a nationwide, open-label, randomized trial initiated in Hungary in March 2020, during the first wave of the COVID-19 pandemic. Participants aged ≥ 60 years were randomly assigned (1:1) to general (group A) or personalized (group B) lifestyle counselling delivered via telephone, targeting mental health, smoking, physical activity, diet, and alcohol consumption. The primary planned endpoint was a composite of COVID-19 severity outcomes; however, due to infection rates, all-cause mortality was assessed. Longitudinal lifestyle changes were evaluated using linear mixed-effects models with bootstrap 95% confidence intervals (CIs) in a modified intention-to-treat population. A total of 441 participants were analyzed (214 group A; 227 group B). All-cause mortality did not differ significantly between groups (HR = 0.66, 95% CI 0.28–1.53). Significant overall time effects were observed for fruit and vegetable consumption ( β = 0.052, CI 0.026–0.074), smoking reduction among current smokers ( β = − 0.372, CI − 0.528 to − 0.222), and psychological variables. A significantly greater reduction in estimated alcohol consumption was observed in group B among baseline drinkers compared with group A ( β = − 1.357, CI − 2.425 to − 0.187), particularly in women. However, BMI among participants with obesity increased in group B ( β = 0.068, CI 0.013–0.119). Seasonal and pandemic-wave effects significantly influenced physical activity and psychological distress. The personalized intervention was not associated with a significant reduction in all-cause mortality. Several lifestyle behaviors improved over time; however, the additional benefit of personalization was limited (Supported by the Semmelweis University Research, Development and Innovation Fund, ClinicalTrials.gov number, NCT04321928).
Authors
- András Varró (ORCID: https://orcid.org/0000-0003-0745-3603)
- Fanni Dembrovszky (ORCID: https://orcid.org/0000-0001-6953-3591)
- Szilárd Váncsa (ORCID: https://orcid.org/0000-0002-9347-8163)
- Eszter Hegyi (ORCID: https://orcid.org/0000-0002-9137-7561)
- Anett Szakolczai
- Nóra Vörhendi (ORCID: https://orcid.org/0000-0001-6972-1154)
- Szabolcs Kiss (ORCID: https://orcid.org/0000-0001-5032-866X)
- Noémi Zádori (ORCID: https://orcid.org/0000-0003-2052-0305)
- Tamás Habon (ORCID: https://orcid.org/0000-0002-4816-857X)
- Zoltán Péterfi (ORCID: https://orcid.org/0000-0001-9658-153X)
- Zsolt Molnár (ORCID: https://orcid.org/0000-0002-1468-4058)
- Klementina Ocskay (ORCID: https://orcid.org/0000-0001-5848-2506)
- Márk Félix Juhász (ORCID: https://orcid.org/0000-0001-7583-5211)
- Árpád Csathó (ORCID: https://orcid.org/0000-0002-0284-654X)
- Béla Birkás (ORCID: https://orcid.org/0000-0002-6380-7093)
- Borbála Zsigmond (ORCID: https://orcid.org/0000-0002-3963-4962)
- Piroska Pázmány (ORCID: https://orcid.org/0000-0002-7492-0235)
- István Kiss (ORCID: https://orcid.org/0000-0002-7558-1300)
- Zsuzsanna Helyes (ORCID: https://orcid.org/0000-0003-2435-4367)
- Andrea Sárközi
- Anna Hegyi
- Andrea Szentesi (ORCID: https://orcid.org/0000-0003-2097-6927)
- László Czopf (ORCID: https://orcid.org/0000-0001-9565-0732)
- Zsolt Szakács (ORCID: https://orcid.org/0000-0002-7035-941X)
- Andrea Párniczky (ORCID: https://orcid.org/0000-0003-3466-4780)
- Anna Kanjo
- Zsolt Abonyi‐Tóth (ORCID: https://orcid.org/0000-0002-5585-3313)
- Anikó Vargáné Nagy (ORCID: https://orcid.org/0000-0001-5868-3156)
- Dóra Czapári
- Dalma Dobszai (ORCID: https://orcid.org/0000-0002-8703-1381)
- Erika Pintér (ORCID: https://orcid.org/0000-0001-9898-632X)
- Gábor Pethö (ORCID: https://orcid.org/0000-0002-3029-4148)
- Nelli Farkas (ORCID: https://orcid.org/0000-0002-5349-6527)
- Roland Molontay (ORCID: https://orcid.org/0000-0002-0666-5279)
- Mária Földi (ORCID: https://orcid.org/0000-0003-4534-0394)
- Attila Márta
- Lajos Szakó (ORCID: https://orcid.org/0000-0001-9783-4076)
- Katalin Márta (ORCID: https://orcid.org/0000-0002-2213-4865)
- Dominika Tóth
- P ter Hegyi (ORCID: https://orcid.org/0000-0003-0399-7259)
- Emőke Miklós
- Zsanett Macht-Szalai (ORCID: https://orcid.org/0009-0009-3898-4715)
- Antal Zemplenyi (ORCID: https://orcid.org/0000-0002-0177-0264)
- Péter Jenő Hegyi (ORCID: https://orcid.org/0000-0003-0399-7259)
- Bálint Erőss
- Judit Hegyi
- PROACTIVE-19 Trial Contributors
- Richárd Farkas
Institutions
- Semmelweis University (HU)
- University of Szeged (HU)
- Budapest University of Technology and Economics (HU)
- Heim Pál Országos Gyermekgyógyászati Intézet (HU)
- University of Pecs (HU)
Publication Details
- Journal
- GeroScience
- Published
- 2026-10-19
- DOI
- https://doi.org/10.1007/s11357-026-02585-1
- Primary Topic
- Telemedicine and Telehealth Implementation
- Type
- article
- Field-Weighted Citation Impact
- 0.00